Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects

NCT04030559 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
11
Enrollment
OTHER
Sponsor class

Stopped PI choice; poor accrual

Conditions

Interventions

Sponsor

University of California, Davis

Collaborators